Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2330 (LINC02330) is a gene that encodes a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs that are typically longer than 200 nucleotides and located between protein-coding genes[1][3][5]. LincRNAs, including LINC02330, do not encode proteins but can regulate gene expression at transcriptional and post-transcriptional levels through mechanisms such as chromatin remodeling, regulation of transcription, and influencing the stability of other RNA molecules[3][5][7]. While lincRNAs are increasingly recognized for their important roles in fine-tuning gene expression and potentially contributing to disease processes, most specific lincRNAs, including LINC02330, remain poorly characterized with respect to discrete molecular function, disease association, or potential as therapeutic targets[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2330 (LINC02330).